P53ABN

Clinical trials for P53ABN explained in plain language.

Never miss a new study

Get alerted when new P53ABN trials appear

Sign up with your email to follow new studies for P53ABN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill aims to keep aggressive uterine cancer at bay

Disease control Recruiting now

This study is testing if taking a targeted pill called olaparib for one year after finishing standard chemo and radiation can help prevent a specific, aggressive type of endometrial cancer from returning. It will compare the pill to just watching closely (observation) in over 550…

Matched conditions: P53ABN

Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

P53ABN

Get alerted when new P53ABN trials appear

New pill aims to keep aggressive uterine cancer at bay